本文目的是通过复习有关高催乳素血症患者骨质疏松病因方面的资料,来确定是否多巴胺能治疗 可以成功地减少病人骨折的危险性,或者至少避免患者骨密度进一步减少。 Klibaski等人发现雌激素水平最低的那些高催乳素血症患者的骨矿物质含量(BMC)减少最严重。他们提出这种骨营养不良的原因是雌激素缺乏,而并非由于高催乳素血症本身所致,但是在他 The purpose of this article is to review the literature on the etiology of osteoporosis in patients with hyperprolactinemia to determine whether dopaminergic treatment can successfully reduce the risk of patient fracture or at least prevent further reduction of BMD. Klibaski et al. Found that patients with hyperprolactinemia who had the lowest levels of estrogen had the greatest reduction in bone mineral content (BMC). The reason they proposed this osteodystrophy is estrogen deficiency, not due to hyperprolactinemia itself, but in his